Our Oversight Board

Keogh, Sir Bruce - Headshot

Professor Sir Bruce Keogh (Chair)​

“This new initiative is a boost in the arm for clinical cardiovascular research in the UK. We are offering an infrastructure firstly to help the clinical community identify the most important, relevant research questions and to address those issues by supporting the planning and delivery of well designed, world-class research across the NHS.”

Sir Bruce is currently chair of the Birmingham Women’s and Children’s NHS FT,  a position he has held since 2018. Following a career as a cardiac surgeon in London and Birmingham, including periods as a BHF Junior Research Fellow and Senior Lecturer and professor at University College London, Sir Bruce was appointed Director General in the Department of Health and Medical Director of the NHS in 2007, a role which migrated to the board of a new independent NHS Commissioning Board (NHS England) in 2013. As the National Medical director 2007-2018, he was responsible for overall clinical policy and strategy, innovation and clinical leadership in the NHS. This included medical and dental care, diagnostics and pharmacy. Prior to this, he served as a Commissioner on the boards of the healthcare regulators the Commission for Health Improvement and the Healthcare Commission from 2002 to 2007. He has served as President of the Society for Cardiothoracic Surgery in Great Britain and Ireland, Secretary General of the European Association for Cardio-Thoracic Surgery, President of the Cardiothoracic Section of the Royal Society of Medicine and the board of directors of the Society of Thoracic Surgeons in the United States and the Council of the Royal College of Surgeons of England. He was knighted for services to medicine in 2003 and listed by the Sunday Times in 2014 as one of Britain’s 100 most influential people.  

Professor Bryan Williams

"The BHF CRC stands as a testament to our shared commitment to innovation and support for cardiovascular clinical research. We take pride in empowering researchers through a robust support system, fostering an environment that encourages interdisciplinary connections."

Bryan joined the BHF in 2023. He oversees one of the largest funding portfolios for academic cardiovascular research portfolios globally. He has 40 years’ experience in the NHS where he works as a Consultant Physician with a specialist clinical interest in hypertension in which he is recognised as a world leading authority. 

Bryan is currently Chair of Medicine at University College London and was formerly Director of the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre. As Director of Research at UCLH he oversaw one of the most complex clinical trial programmes in the NHS (2012-2023).  

He is a Fellow of the Academy of Medical Sciences and in the 2023 Clarivate listings was recognised as one of the worlds’ most influential scientists in his field. He has published extensively in major medical and scientific journals and has contributed to many pivotal clinical trials in hypertension and cardiovascular medicine. 

Bryan is a Trustee for Blood Pressure UK and In2Science, a charity supporting mentoring for talented young people from the most disadvantaged backgrounds to increase their chances to study science at the UK’s leading universities. 

He was awarded an OBE in the 2024 New Year’s honours list, for his services to medicine. 

Huon Gray 2

Professor Huon Gray

“The UK is fortunate to have many talented individuals and organisations undertaking cardiovascular research, but often their work is undertaken in silos and sometimes with overlapping objectives. The BHF CRC aims to support collaborative research and I’m delighted to join others on the Oversight Board in providing strategic oversight of this worthwhile initiative."

Huon Gray was appointed consultant adult and interventional cardiologist to Southampton University Hospital in 1989He was President of the British Cardiac Society (2003-5)receiving its Mackenzie Medal in 2014, and co-chaired the Dept. of Health’s National Infarct Angioplasty Project (2006-8), which led to the subsequent national roll out of primary PCI for ST elevation myocardial infarctionHe was also clinical adviser and then chair of two NICE guidelines on acute coronary syndromes (2007-13). He is honorary professor at Queen Mary’s University, London and has published widely on various aspects of cardiology and health service delivery.  

Huon has served in various capacities within the American College of Cardiology (ACC); as chair of its International Council (2008-13), on its Board of Trustees (2012-16), and currently chair of its Governance Committee (2019-22). He received the ACC’s Presidential Citation in 2013, and designation as Master of the ACC in 2018. 

He was Deputy and then Interim National Clinical Director for Heart Disease at the Department of Health (2007-12), co-producing its CVD Outcomes Strategy (2013), and was then  National Clinical Director for Heart Disease in NHS England between 2013-19. He was made Commander of the Excellent Order of the British Empire (CBE) in the Queen’s New Year’s Honours list 2019. 

Professor David Crossman

“The BHF CRC has the enormous potential of bring research together from the wide range of professional groups and bodies in cardiovascular medicine in the UK with the support of the BHF. Cardiovascular research is world-leading in the UK and has a long and impressive history. The BHF CRC will allow this reputation to be maintained and grow. Cardiovascular disease still removes too many years of life, and often productive and important years, from individual members of the population of the UK. The BHF CRC will be part of the way we can collectively challenge the impact of cardiovascular disease and is an initiative that I am pleased to help and be part of.”

Professor David Crossman is Dean of the Faculty of Medicine and Head of the School of Medicine at the University of St Andrews. He moved to Scotland over six years ago having run the medical school at the University of East Anglia. Prior to that he was Professor of Clinical Cardiology at the University of Sheffield, a post that he took up in 1994.

He has practiced as a regional centre cardiologist with an interest in interventional cardiology and heart disease in pregnancy. He continues to hold an honorary consultant cardiologist at NHS Fife where he has weekly clinical commitments in general outpatients. His research interest is in the inflammatory basis of coronary artery disease and clinical trials.

In 2017 he was appointed Chief Scientist for Health to Scottish Government, a seconded post for two days per week. He advises on health matters and clinical research funded by the Scottish Government through the Chief Scientists Office.

Kelvin Photo with border

Mr Kelvin Pitman

“Having spent three years on the BHF Clinical Studies Committee, I was often struck by the degree of overlap between applications for funding. It became clear to me that if excellent talent and limited resources were not to be wasted, some mechanism to help cardiovascular researchers avoid undue overlap would be very worthwhile. Hence on behalf of all potential beneficiary I was delighted to be invited to bring a patient’s perspective to the BHF CRC Oversight Board”

Born in 1950, Kelvin grew up in South West London, is married to a retired primary school teacher and has two daughters. He has a BSc in Chemical and Polymer Technology and worked most of his life in large international packaging companies, retiring in 2011. 

Having suffered a heart attack 13 years ago, Kelvin had a stent fitted and recovered well but was left with some heart failure. AF has become problematic leading to several rounds of external cardioversion. 4 year ago a CRT-D device was fitted followed by unsuccessful internal cardioversion. 

He enjoys skiing, cycling, walking, DIY and maintaining a 1975 MGB roadster. One daughter, married to an airline pilot living in Dubai with 3 young grandchildren keep Kelvin busy with regular visits both waysHis other daughter is an early years lecturer at a famous nanny training college. 

His career started within R&D working with customers, often using statistics on test data to ensure the company’s products met customers’ specifications. Kelvin subsequently moved into marketing using consumer research to understand consumers’ softer needs. 

He worked 15 years in Switzerland becoming Technical Director of a company. Then an R&D Director managing four development groups across the USA, UK and Switzerland. 

Another significant part of Kelvins career is associated with intellectual property, such as patents, license agreements, and technical transfer. Latterly, he was heavily involved in Open Innovation whereby companies in different fields cooperate to use similar technology for different purposes. 

Kelvin serves as a patient on a BHF/CRUK data advisory panel, recently retired from the BHF Clinical Studies Committee and just joined a MRC CTU at UCL focusing on Covid-19. 

Professor John Greenwood

“I am delighted that the BCS are hosting such an important initiative. The BHF CRC will offer practical support for sharing project ideas, research planning and supporting clinicians who want to engage in research, providing a much needed step change for cardiovascular clinical research in the UK”

John Greenwood is a Professor of Cardiology in the Leeds Institute for Cardiovascular and Diabetes Research (LICAMM) and Consultant Cardiologist at Leeds Teaching Hospitals NHS Trust, where he specialises in coronary intervention and cardiovascular magnetic resonance (CMR) imaging.

He qualified in medicine from Leeds in 1991 and after general medical training in Yorkshire undertook a clinical PhD in Leeds, funded by the British Heart Foundation. His main area of research is the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involves the use of CMR in terms of its development and validation through clinical trials. He was Chief Investigator on the landmark CE-MARC trial (Lancet 2012) and the CE-MARC 2 trial (JAMA 2016). In terms of therapeutics, he is collaborating on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction.

He is President of the British Cardiovascular Society (BCS) (2021-2024) having been Vice President for Research & Education (2017-2020). He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2009, and is the immediate-past President of the Society (2018-2020). He is past-Chair of the SCMR Clinical Trials Committee and was the SCMR representative on the writing group of the 2021 AHA/ACC/ASE/ASNC/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain.

For 10 years Prof. Greenwood led the supra-regional CMR service in Leeds, one of the UKs largest, and as an interventional cardiologist actively contributes to the coronary intervention service for West Yorkshire, including the regional primary PCI service. He is Director of the Cardiovascular Clinical Research Facility at Leeds Teaching Hospitals NHS Trust.

John Greenwood image

Doctor Tony Soteriou

“I am delighted to be involved with the oversight Board for the BHF CRC, and the aim to promote excellence in UK cardiovascular clinical research. Like many of us I have had first hand experience of the impact cardiovascular disease on family and friends, and am passionate about the role clinical research plays in saving and improving the quality of lives. Aligning the great work of the BHF CRC with research funders including UK Research and Innovation will be an important aspect in achieving success.”

Tony leads UKRI’s activity in the commercialisation of research, directing UKRI’s efforts to harness and exploit research to deliver economic impact for the UK. 

Tony’s role started in February 2020 and has the aim of creating new UKRI shared capability for commercialisation, working with and complementing commercialisation: across business-led innovation by Innovate UK, the work of the research councils, and  Research England’s role in driving high quality university research and knowledge exchange. 

Prior to working at UKRI, Tony worked as Deputy Director for Research Faculty, Infrastructure and Growth, within the Department of Health and Social Care for over nine years, where his responsibilities included leading on industry R&D relations and supporting and promoting economic growth.  Prior to that, Tony was Director of Research with a large mental health NHS Trust, and before that held a research management post within the South West NHS Executive.  His first research management post was at the Medical Research Council, following a PhD in Biochemistry from Cardiff University and postdoctoral research at the University of Bristol. 

He has extensive experience as a senior research policy and management leader, with 25 years of research leadership, strategy, commissioning and delivery within a wide variety of research and management environments.